Skip to content
The Nexus
BUSINESSJun 3 · 11:06 UTCCNBC TOP

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

Eli Lilly's top dealmaker discusses increased M&A activity to expand into new areas. The company has changed its M&A approach following its status as the most valuable pharmaceutical company in the world.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Eli LillyorganizationM&Atopicpharmaceutical companytopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting